Home > Cashflow Statement > INDO US BIOTECH

INDO US BIOTECH
Cashflow Statement

COMMUNITY POLL
for INDO US BIOTECH
Please provide your vote to see the results

INDO US BIOTECH Last 5 Year Cashflow Statement History

[Standalone]

Mar2026Mar2025Mar2024Mar2023Mar2022
Profit Before Tax₹14 Cr₹17 Cr₹8.80 Cr₹7.39 Cr₹5.49 Cr
Adjustment ₹3.50 Cr₹3.00 Cr₹2.25 Cr₹2.02 Cr₹1.62 Cr
Changes In working Capital ₹-30 Cr₹-18 Cr₹-15 Cr₹-8.56 Cr₹-3.81 Cr
Cash Flow after changes in Working Capital ₹-12 Cr₹1.77 Cr₹-4.27 Cr₹0.84 Cr₹3.30 Cr
Cash Flow from Operating Activities ₹-13 Cr₹1.42 Cr₹-4.58 Cr₹0.53 Cr₹2.91 Cr
Cash Flow from Investing Activities ₹-1.50 Cr₹-0.79 Cr₹4.28 Cr₹-6.67 Cr₹-5.40 Cr
Cash Flow from Financing Activities ₹20 Cr₹-1.48 Cr₹1.22 Cr₹6.29 Cr₹2.41 Cr
Net Cash Inflow / Outflow ₹5.88 Cr₹-0.85 Cr₹0.91 Cr₹0.14 Cr₹-0.08 Cr
Opening Cash & Cash Equivalents ₹0.25 Cr₹1.10 Cr₹0.19 Cr₹0.05 Cr₹0.13 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations -----
Closing Cash & Cash Equivalent ₹6.12 Cr₹0.25 Cr₹1.10 Cr₹0.19 Cr₹0.05 Cr

Compare Cashflow Statement of peers of INDO US BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDO US BIOTECH ₹173.7 Cr 27.2% 7.4% -41.5% Stock Analytics
KAVERI SEED COMPANY ₹3,607.9 Cr -4.4% -13% -35.9% Stock Analytics
VENKYS (INDIA) ₹2,221.9 Cr -3.3% -4.5% 10.5% Stock Analytics
AVT NATURAL PRODUCTS ₹1,393.4 Cr 3.7% -1.2% 30.8% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹883.1 Cr -5.1% -4.4% NA Stock Analytics
MANGALAM GLOBAL ENTERPRISE ₹587.6 Cr 4.5% 11.6% 15% Stock Analytics


INDO US BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDO US BIOTECH

27.2%

7.4%

-41.5%

SENSEX

-0.6%

-0.5%

-13.2%


You may also like the below Video Courses